Weekly science reads: senescence, alt CRISPR, sickle cell update

0


Is 2022 going to be any better than 2020 or 2021 when it comes to things in general or for biomedical science? Related to the pandemic?

It’s too soon to say but if I had to guess right now I’d venture an optimistic view that overall it’s going to be somewhat better by the end of the year.

What do you think?

For science more specifically, on one level, biomedical research has flourished during the pandemic in the sense of saving possibly millions of lives quickly. Also, hopefully most people have a better appreciation of its importance. On the other hand, COVID has substantially slowed down research more generally.

My new experiment with a stem cell channel on YouTube had a pretty good 2021 and we are now at more than 330 subscribers. Check it out and subscribe if you like some of the videos. I posted my newest video above, which is on 293 cells. They have been much in the news related to their use in COVID vaccine research.

On to the recommended reads.

victoria gray family crispr sickle cell b
Victoria Gray and her kids. She was the first trial participant to receive an experimental CRISPR intervention for sickle cell disease. Via an update from NPR we know that she is doing great so far a year after getting the transplant of gene-edited cells. Photo by Victoria Gray.

Stem cell and other science papers

News & Resources



Source link

Leave A Reply

Your email address will not be published.